Statistical Considerations for Clinical Trials During COVID-19: Phase 1 Cancer Trials

Document Type

Article

Publication Date

4-20-2020

Publication Title

LinkedIn

Abstract

Oncology drug discovery and proper conduct of cancer clinical trials are essential to our battle against cancer. According to a 2015 Center for Disease Control and Prevention (CDC) report, the expected cancer cases and deaths in 2020 are 1.9 million and 630,000. While the world is fighting COV-19 pandemic, it is also important to be more creative than ever to continue anti-cancer drug development in a safe manner - without exposing cancer patients to unnecessary COVID-19 risks while maintaining the integrity of cancer clinical trials.

Link to Full Text

Share

COinS